Life expectancy after starting antiretroviral therapy for HIV has risen over the years in both high-income and low/middle-income countries, according to a new meta-analysis.
This week, a study finds that condomless sex among men living with HIV has risen during the treatment-as-prevention era. Another study finds that statins are less effective in people with HIV who have lower baseline vitamin D levels.
This Week in HIV Research: Proposed Federal Budget Cuts Would Disrupt Health Research; and Viral Load Differences
This week, a report in Nature finds that proposed federal budget cuts to the National Institutes of Health could impair long-term studies and prevention research.
This Week in HIV Research: How Thailand Eliminated Mother-to-Child Transmission; and Maraviroc for Pre-Exposure Prophylaxis
This week, a study reviews how Thailand eliminated nearly all mother-to-child transmission of HIV.
This Week in HIV Research: Early Treatment May Prevent Severe Weight Gain; and Pharmacists Willing to Prescribe PrEP, With Training
This week, a study finds that starting treatment earlier helped prevent severe weight gain in African Americans with HIV.
This week, a study finds that a two-drug regimen of cabotegravir and rilpivirine works as maintenance therapy, according to 144-week results.
This Week in HIV Research: Kidney Function Improves With Protease Inhibitor Switch; and Viral Load Blips Predict Post-Treatment Control
This week, a study finds switching a protease inhibitor-based regimen from lopinavir or atazanavir to darunavir helps improve kidney function. Another study finds that viral load blips during early HIV treatment help predict post-treatment control....
This Week in HIV Research: Diabetes Rate Higher Among People With HIV; and 8-Week Hepatitis C Treatment for HIV/HCV Coinfection
This week, a study finds that people living with HIV are more likely to develop diabetes than the general population. Another study finds that 8 weeks of hepatitis C (HCV) treatment is highly effective in those with HIV/HCV coinfection.
Pretreatment CD4 count strongly predicted mortality in the first years of antiretroviral therapy, according to analysis of 18 cohorts in Europe and North America.
This Week in HIV Research: Long-Term Adherence Interventions Needed; and Preventing a Third of New HIV Infections
This week, a study finds that interventions to improve adherence often stop working over time and that long-term solutions are needed.